Plague agent helps UT Southwestern researchers find novel signaling system in cells

May 25, 2006

DALLAS -- The bacterium that causes bubonic plague would seem unlikely to help medical scientists, but researchers at UT Southwestern Medical Center have harnessed it to uncover a new regulatory mechanism that inhibits the immune system.

Three species of the Yersinia bacteria, known to cause plague and gastroenteritis, contain a small molecule, called a virulence factor, that the researchers have found modifies host enzymes critical to normal functioning.

"This type of modification has never been seen in cells and presents a new paradigm for how cells may regulate signaling," said Dr. Kim Orth, assistant professor of molecular biology and senior author of the study appearing in the May 26 edition of Science.

"Yersinia is a nasty pathogen that uses an arsenal of virulence factors to cause disease," she said.

When a cell is infected with a bacterial pathogen, it activates a chain of reactions involving enzymes. One enzyme adds a group of atoms containing phosphorus - called a phosphate group - to another enzyme, a process called phosphorylation, which spurs that enzyme to add a phosphate group to yet another enzyme, and so on. These "cascading" events trigger an appropriate immune response.

Yersinia, however, has the ability to prevent its host from mounting the response, enabling the bacteria to survive and multiply.

The researchers found that one of the Yersinia outer proteins, called YopJ, cripples these cascades by adding a small molecule called an acetyl group to two key sites on a host enzyme where the phosphate groups are usually added.

Because the host's enzymes are modified by acetyl groups, they can no longer be activated by phosphate groups, and the enzymatic cascade critical for triggering an innate immune response is not activated.

The internal signaling that YopJ affects is common to many species, from yeast to mammals. In addition, other pathogens that attack animals and plants use proteins that are similar to YopJ.

The research is not geared toward finding a cure for plague, which affects about a dozen people in the United States a year and is treatable with antibiotics. Instead, the scientists are working to find out how the pathogen disrupts the immune system and to understand the machinery critical for stimulating an immune response.

"There are many virulence factors used by bacterial pathogens to co-opt the host signaling molecules," Dr. Orth said. "These virulence factors affect central signaling machinery, and we want to understand how they are doing it."

Understanding the relationship between the pathogens and the hosts will help researchers uncover critical steps in how host cells normally operate, Dr. Orth said.

"The next step is to see whether the addition of acetyl groups to key sites on enzymes during cellular signaling is normal for animal and plant cells, and if so, under what circumstances," said Dr. Orth.
-end-
Other UT Southwestern researchers involved in the study were first author Sohini Mukherjee, student research assistant in molecular biology; Gladys Keitany, research assistant in molecular biology; Dr. Yan Li, instructor of biochemistry; Yong Wang, research assistant in molecular biology; Dr. Haydn Ball, assistant professor of biochemistry; and Dr. Elizabeth Goldsmith, professor of biochemistry.

The work was supported by the National Institute of Allergy and Infectious Diseases, the Beckman Foundation and the Welch Foundation.

This news release is available on our World Wide Web home page at http://www.utsouthwestern.edu/home/news/index.html

To automatically receive news releases from UT Southwestern via e-mail,subscribe at www.utsouthwestern.edu/receivenews

Researcher's bio - http://www.utsouthwestern.edu/findfac/professional/0,2356,52806,00.html

UT Southwestern Medical Center

Related Immune System Articles from Brightsurf:

How the immune system remembers viruses
For a person to acquire immunity to a disease, T cells must develop into memory cells after contact with the pathogen.

How does the immune system develop in the first days of life?
Researchers highlight the anti-inflammatory response taking place after birth and designed to shield the newborn from infection.

Memory training for the immune system
The immune system will memorize the pathogen after an infection and can therefore react promptly after reinfection with the same pathogen.

Immune system may have another job -- combatting depression
An inflammatory autoimmune response within the central nervous system similar to one linked to neurodegenerative diseases such as multiple sclerosis (MS) has also been found in the spinal fluid of healthy people, according to a new Yale-led study comparing immune system cells in the spinal fluid of MS patients and healthy subjects.

COVID-19: Immune system derails
Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.

Immune cell steroids help tumours suppress the immune system, offering new drug targets
Tumours found to evade the immune system by telling immune cells to produce immunosuppressive steroids.

Immune system -- Knocked off balance
Instead of protecting us, the immune system can sometimes go awry, as in the case of autoimmune diseases and allergies.

Too much salt weakens the immune system
A high-salt diet is not only bad for one's blood pressure, but also for the immune system.

Parkinson's and the immune system
Mutations in the Parkin gene are a common cause of hereditary forms of Parkinson's disease.

How an immune system regulator shifts the balance of immune cells
Researchers have provided new insight on the role of cyclic AMP (cAMP) in regulating the immune response.

Read More: Immune System News and Immune System Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.